XOM Stock Ownership Activity

EXXON MOBIL CORP 13F holders

6 value investing gurus have made changes to the EXXON MOBIL CORP (XOM) position according to the gurus' latest SEC quarterly report(s). XOM has been bought (as a new position) by 1 guru(s), the number of XOM shares has been increased by 3, decreased by 2 super investor(s).

Which gurus or hedge funds are buying XOM now?

According to the latest SEC filing(s) EXXON MOBIL CORP (XOM) has been bought by 4 gurus: Ravenel Boykin Curry IV - Eagle Capital Management (new buy), Christopher Bloomstran - Semper Augustus Investments Group (added shares +2.8%), Thomas Russo - Gardner Russo & Quinn (added shares +0.52%) and Paul Lountzis - Lountzis Asset Management (added shares +6.89%).

To see more about who is investing in EXXON MOBIL CORP (XOM), please go to the XOM ownership page.

2024 Q1 (6 results)
Ravenel Boykin Curry IV
buy
+2,690
+0.00%
0.00%
Paul Lountzis
+6.89%
+337
+0.02%
0.29%
Christopher Bloomstran
+2.80%
+1,575
+0.03%
1.23%
Thomas Russo
+0.52%
+935
+0.00%
0.21%
Thomas Graham, Alan, Irving Kahns
-6.94%
-533
-0.02%
0.12%
Donald Yacktman
-17.19%
-25,000
-0.03%
0.13%
Current price: $117.33 0.93% AVG reported price*: $116.25
2023 Q4 (5 results)
Thomas Russo
+0.57%
+1,019
+0.00%
0.18%
Donald Yacktman
-1.09%
-1,024
-0.00%
0.09%
Thomas Graham, Alan, Irving Kahns
-1.39%
-214
-0.00%
0.24%
Paul Lountzis
-12.11%
-900
-0.05%
0.36%
Bill Gates
-100.00%
-8,925
-0.00%
0.00%
Current price: $117.33 17.35% AVG reported price*: $99.98
2023 Q3 (6 results)
Bill Gates
buy
+8,925
+0.01%
0.00%
Thomas Graham, Alan, Irving Kahns
+10.62%
+1,044
+0.03%
0.20%
Thomas Russo
-0.13%
-132
-0.00%
0.13%
Donald Yacktman
-1.87%
-2,800
-0.00%
0.17%
Christopher Bloomstran
-24.23%
-18,013
-0.51%
1.59%
Ronald Muhlenkamp
-100.00%
-1,952
-0.07%
0.00%
Current price: $117.33 0.21% AVG reported price*: $117.58
2023 Q2 (5 results)
Donald Yacktman
+1.84%
+2,700
+0.00%
0.15%
Thomas Russo
+0.76%
+1,341
+0.00%
0.19%
Thomas Graham, Alan, Irving Kahns
-2.10%
-300
-0.00%
0.22%
Paul Lountzis
-2.62%
-157
-0.01%
0.36%
Christopher Bloomstran
-16.90%
-9,373
-0.38%
1.17%
Current price: $117.33 8.44% AVG reported price*: $108.20
2023 Q1 (4 results)
Thomas Russo
+0.35%
+610
+0.00%
0.20%
Donald Yacktman
-2.00%
-2,009
-0.00%
0.11%
Thomas Graham, Alan, Irving Kahns
-4.08%
-421
-0.01%
0.16%
Christopher Bloomstran
-12.50%
-11,500
-0.36%
2.26%
Current price: $117.33 7.00% AVG reported price*: $109.66
2022 Q4 (6 results)
Ronald Muhlenkamp
buy
+1,952
+0.09%
0.09%
Thomas Graham, Alan, Irving Kahns
-0.32%
-30
-0.00%
0.14%
Thomas Russo
-1.47%
-2,641
-0.00%
0.21%
Christopher Bloomstran
-16.43%
-20,108
-0.60%
3.07%
Donald Yacktman
-18.02%
-33,000
-0.04%
0.16%
David Rolfe
-100.00%
-1,852
-0.04%
0.00%
Current price: $117.33 6.37% AVG reported price*: $110.30
2022 Q3 (6 results)
David Rolfe
buy
+1,852
+0.04%
0.00%
Thomas Russo
+0.47%
+513
+0.00%
0.12%
Paul Lountzis
+0.10%
+8
+0.00%
0.45%
Donald Yacktman
-21.65%
-48,323
-0.05%
0.17%
Christopher Bloomstran
-23.32%
-37,212
-0.98%
3.23%
Thomas Graham, Alan, Irving Kahns
-32.87%
-7,300
-0.10%
0.20%
Current price: $117.33 34.39% AVG reported price*: $87.30
2022 Q2 (5 results)
Thomas Graham, Alan, Irving Kahns
+45.50%
+6,111
+0.08%
0.23%
Christopher Bloomstran
+0.30%
+471
+0.01%
4.05%
Thomas Russo
-0.89%
-1,599
-0.00%
0.17%
Paul Lountzis
-0.97%
-62
-0.00%
0.36%
David Rolfe
-100.00%
-2,500
-0.04%
0.00%
Current price: $117.33 37.01% AVG reported price*: $85.64
2022 Q1 (7 results)
David Rolfe
buy
+2,500
+0.03%
0.00%
Thomas Russo
+0.44%
+481
+0.00%
0.09%
Christopher Bloomstran
-0.09%
-149
-0.00%
3.34%
Donald Yacktman
-0.21%
-377
-0.00%
0.13%
Thomas Graham, Alan, Irving Kahns
-1.93%
-300
-0.00%
0.16%
Mark A. Hillman
-100.00%
-108,000
-2.68%
0.00%
Duan Yongping
-100.00%
-899,700
-0.58%
0.00%
Current price: $117.33 42.05% AVG reported price*: $82.60
50 of 239

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.